Co-IP analysis further showed that ZMYND8 interacts with EZH2 at endogenous levels in two ccRCC cell lines examined, but no ZMYND8 binding of EZH1, SUZ12, or EED was detected (Fig. 4 C and D). This evidence concerns the gene EZH2 and nonpapillary renal cell carcinoma.